Who
G. Jan Van Heek
Director
Company insider
Files Form 4 as: Director, Minerva Neurosciences; Director, Amarin Corporation; Director, Viacell.
In numbers
- Trades disclosed
- 69
- Buys
- 3
- Sells
- 4
- Bought
- $94K
- Sold
- $4.6M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 19 May 2006
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Dec 2024filed 6 Dec 2024 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 27 Sep 2023filed 29 Sep 2023 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 27 Jun 2022filed 29 Jun 2022 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,919 at $0.00 | filing |
| 27 Jun 2022filed 29 Jun 2022 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,750 at $0.00 | filing |
| 10 Jun 2022filed 28 Jun 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 14 Jun 2021filed 16 Jun 2021 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,953 at $0.00 | filing |
| 14 Jun 2021filed 16 Jun 2021 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 10 Sep 2020filed 11 Sep 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $21K7,000 at $2.97 | filing |
| 13 Jul 2020filed 15 Jul 2020 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,805 at $0.00 | filing |
| 13 Jul 2020filed 15 Jul 2020 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,191 at $0.00 | filing |
| 11 Jun 2020filed 12 Jun 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 26 Jun 2019filed 27 Jun 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $54K10,000 at $5.37 | filing |
| 31 May 2019filed 31 May 2019 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 May 2019filed 21 May 2019 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,658 at $0.00 | filing |
| 20 May 2019filed 21 May 2019 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,428 at $0.00 | filing |
| 22 Feb 2019filed 22 Feb 2019 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —90,000 at $0.00 | filing |
News
Amarin (NASDAQ:AMRN) and Merck KGaA (OTCMKTS:MKKGY) Financial ReviewAMRN · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name G. Jan Van Heek; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.